Figma Shares Indicated To Open $105/$110
James H. Roth, a director at Huron Consulting Group Inc. (NASDAQ:HURN), recently sold a significant amount of the company’s common stock. According to a Form 4 filing with the Securities and Exchange Commission, Roth sold a total of 8,641 shares on March 26, 2025. The transactions were executed at prices ranging from $141.30 to $145.62 per share, resulting in total proceeds of approximately $1.23 million. The sale comes as the company’s stock has shown remarkable strength, with a 47.7% return over the past year and a 32.1% gain in the last six months, according to InvestingPro data.
The sales were conducted under a pre-established Rule 10b5-1 trading plan, which Roth adopted on May 18, 2024. Following these transactions, Roth holds 47,638 shares directly and an additional 3,855 shares indirectly through a family LLC. With a market capitalization of $2.33 billion and an overall financial health score rated as "GREAT" by InvestingPro, Huron maintains a strong market position.
Huron Consulting Group, based in Chicago, Illinois, provides management consulting services and is listed on the NASDAQ under the ticker HURN. The company currently trades at a P/E ratio of 21.8 and has demonstrated solid profitability with a gross margin of 32%. For deeper insights into Huron’s valuation and growth prospects, investors can access comprehensive analysis through InvestingPro, which offers exclusive ProTips and detailed financial metrics.
In other recent news, Huron Consulting Group reported impressive fourth-quarter 2024 financial results, with earnings per share (EPS) of $1.90, surpassing the analyst estimate of $1.52. The company also achieved record Q4 revenue of $399.31 million, exceeding the consensus estimate of $379.99 million. Huron’s full-year 2024 results showed a 9.1% increase in revenues to a record $1.49 billion and an 86.7% increase in net income to $116.6 million. Additionally, Huron announced an increase in its share repurchase program, now authorizing a total of $700 million in buybacks, reflecting confidence in its financial health.
Truist Securities maintained a Buy rating on Huron, raising the price target to $180, with expectations for growth in healthcare and higher education sectors. Analyst Tobey Sommer noted potential benefits from federal spending changes and revised the 2026 EPS estimate upward to $8.28. Benchmark analyst Bill Sutherland also raised Huron’s price target to $165, citing strong Q4 performance and optimistic 2025 guidance. Both analysts highlighted Huron’s strategic positioning and opportunities in healthcare and education.
Huron’s management outlined ambitious goals, including a 15% compound annual growth rate in EPS over the next five years. The company plans to sustain low double-digit revenue growth and expand its adjusted EBITDA margin annually. These developments underscore Huron’s strategic focus on growth and capital allocation, including share repurchases and mergers.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.